Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): A randomised, open-label, phase 3 trial

1. Krop, I.E.
2. Kim, S.-B.
3. González-Martín, A.
4. LoRusso, P.M.
5. Ferrero, J.-M.
6. Smitt, M.
7. Yu, R.
8. Leung, A.C.F.
9. Wildiers, H.